{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:43:13Z","timestamp":1787319793723,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korean government","award":["HX23C1718"],"award-info":[{"award-number":["HX23C1718"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05843-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:18:53Z","timestamp":1751379533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic and clinical distinction between aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma with bone marrow involvement"],"prefix":"10.1038","volume":"15","author":[{"given":"Ju Hyeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Yoon","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Hwan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Woo","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongseok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5843_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2141.1990.tb02615.x","volume":"75","author":"N Imamura","year":"1990","unstructured":"Imamura, N. et al. Aggressive natural killer cell leukaemia\/lymphoma: Report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br. J .Haematol. 75, 49\u201359. https:\/\/doi.org\/10.1111\/j.1365-2141.1990.tb02615.x (1990).","journal-title":"Br. J .Haematol."},{"key":"5843_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","volume":"87","author":"ES Jaffe","year":"1996","unstructured":"Jaffe, E. S. Classification of natural killer (NK) Cell and NK-Like T-Cell malignancies. Blood 87, 1207\u20131210. https:\/\/doi.org\/10.1182\/blood.V87.4.1207.bloodjournal8741207 (1996).","journal-title":"Blood"},{"key":"5843_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0925-5710(96)00450-1","volume":"63","author":"K Oshimi","year":"1996","unstructured":"Oshimi, K. Lymphoproliferative disorders of natural killer cells. Int. J. Hematol. 63, 279\u2013290. https:\/\/doi.org\/10.1016\/0925-5710(96)00450-1 (1996).","journal-title":"Int. J. Hematol."},{"key":"5843_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.leu.2403262","volume":"18","author":"R Suzuki","year":"2004","unstructured":"Suzuki, R. et al. Aggressive natural killer-cell leukemia revisited: Large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18, 763\u2013770. https:\/\/doi.org\/10.1038\/sj.leu.2403262 (2004).","journal-title":"Leukemia"},{"key":"5843_CR5","first-page":"1343","volume":"87","author":"SY Song","year":"2002","unstructured":"Song, S. Y. et al. Aggressive natural killer cell leukemia: Clinical features and treatment outcome. Haematologica 87, 1343\u20131345 (2002).","journal-title":"Haematologica"},{"key":"5843_CR6","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","volume":"89","author":"JK Chan","year":"1997","unstructured":"Chan, J. K. et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89, 4501\u20134513 (1997).","journal-title":"Blood"},{"key":"5843_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102900","author":"S El Hussein","year":"2020","unstructured":"El Hussein, S., Medeiros, L. J. & Khoury, J. D. Aggressive NK cell leukemia: Current State of the art. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12102900 (2020).","journal-title":"Cancers (Basel)"},{"key":"5843_CR8","unstructured":"Akkari, Y. et al. WHO Classification of Tumours: Haematolymphoid Tumours. 5th edn, Vol. 11 (International Agency for Research on Cancer (IARC), 2024)."},{"key":"5843_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","volume":"20","author":"ES Jaffe","year":"1996","unstructured":"Jaffe, E. S. et al. Report of the workshop on nasal and related extranodal angiocentric T\/Natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 20, 103\u2013111 (1996).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","volume":"87","author":"JF Emile","year":"1996","unstructured":"Emile, J. F. et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87, 1466\u20131473 (1996).","journal-title":"Blood"},{"key":"5843_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/bf02983235","volume":"78","author":"K Oshimi","year":"2003","unstructured":"Oshimi, K. Leukemia and lymphoma of natural killer lineage cells. Int. J. Hematol. 78, 18\u201323. https:\/\/doi.org\/10.1007\/bf02983235 (2003).","journal-title":"Int. J. Hematol."},{"key":"5843_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/hon.847","volume":"26","author":"R Suzuki","year":"2008","unstructured":"Suzuki, R., Takeuchi, K., Ohshima, K. & Nakamura, S. Extranodal NK\/T-cell lymphoma: Diagnosis and treatment cues. Hematol. Oncol. 26, 66\u201372. https:\/\/doi.org\/10.1002\/hon.847 (2008).","journal-title":"Hematol. Oncol."},{"key":"5843_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","volume":"36","author":"T Pongpruttipan","year":"2012","unstructured":"Pongpruttipan, T. et al. Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am. J. Surg. Pathol. 36, 481\u2013499. https:\/\/doi.org\/10.1097\/PAS.0b013e31824433d8 (2012).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/pas.0000000000000312","volume":"39","author":"K Takata","year":"2015","unstructured":"Takata, K. et al. Primary cutaneous NK\/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: A cellular lineage and clinicopathologic study of 60 patients from Asia. Am. J. Surg. Pathol. 39, 1\u201312. https:\/\/doi.org\/10.1097\/pas.0000000000000312 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.humpath.2014.11.008","volume":"46","author":"JY Jhuang","year":"2015","unstructured":"Jhuang, J. Y. et al. Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: A relatively higher frequency of T-cell lineage and poor survival for extranasal tumors. Hum. Pathol. 46, 313\u2013321. https:\/\/doi.org\/10.1016\/j.humpath.2014.11.008 (2015).","journal-title":"Hum. Pathol."},{"key":"5843_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/modpathol.2016.47","volume":"29","author":"M Hong","year":"2016","unstructured":"Hong, M. et al. Nasal-type NK\/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: Lineage does not predict clinical behavior. Mod. Pathol. 29, 430\u2013443. https:\/\/doi.org\/10.1038\/modpathol.2016.47 (2016).","journal-title":"Mod. Pathol."},{"key":"5843_CR17","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2010","unstructured":"Suzuki, R. et al. Prognostic factors for mature natural killer (NK) cell neoplasms: Aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann. Oncol. 21, 1032\u20131040. https:\/\/doi.org\/10.1093\/annonc\/mdp418 (2010).","journal-title":"Ann. Oncol."},{"key":"5843_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/jco.2016.68.1619","volume":"35","author":"M Yamaguchi","year":"2017","unstructured":"Yamaguchi, M. et al. Treatments and outcomes of patients with extranodal natural killer\/T-Cell lymphoma diagnosed between 2000 and 2013: A cooperative study in Japan. J. Clin. Oncol. 35, 32\u201339. https:\/\/doi.org\/10.1200\/jco.2016.68.1619 (2017).","journal-title":"J. Clin. Oncol."},{"key":"5843_CR19","doi-asserted-by":"publisher","first-page":"e0130984","DOI":"10.1371\/journal.pone.0130984","volume":"10","author":"Z Yan","year":"2015","unstructured":"Yan, Z. et al. A TNM Staging System for Nasal NK\/T-Cell Lymphoma. PLoS ONE 10, e0130984. https:\/\/doi.org\/10.1371\/journal.pone.0130984 (2015).","journal-title":"PLoS ONE"},{"key":"5843_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","volume":"37","author":"S Li","year":"2013","unstructured":"Li, S. et al. Extranodal NK\/T-cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center. Am. J. Surg. Pathol. 37, 14\u201323. https:\/\/doi.org\/10.1097\/PAS.0b013e31826731b5 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/his.13463","volume":"72","author":"CF Yang","year":"2018","unstructured":"Yang, C. F., Hsu, C. Y. & Ho, D. M. T. Aggressive natural killer (NK)-cell leukaemia and extranodal NK\/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings. Histopathology 72, 955\u2013964 (2018).","journal-title":"Histopathology"},{"key":"5843_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3346\/jkms.2004.19.2.229","volume":"19","author":"CO Sung","year":"2004","unstructured":"Sung, C. O. & Ko, Y. H. Bone marrow is involved in less than 10% of patients with nasal-type NK\/T cell lymphoma at initial diagnosis. J. Korean Med. Sci. 19, 229\u2013233. https:\/\/doi.org\/10.3346\/jkms.2004.19.2.229 (2004).","journal-title":"J. Korean Med. Sci."},{"key":"5843_CR23","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.5045\/br.2020.S011","volume":"55","author":"SH Jeong","year":"2020","unstructured":"Jeong, S. H. Extranodal NK\/T cell lymphoma. Blood Res. 55, S63-s71. https:\/\/doi.org\/10.5045\/br.2020.S011 (2020).","journal-title":"Blood Res."},{"key":"5843_CR24","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/cncr.34473","volume":"128","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. The value of routine bone marrow examination in patients with extranodal NK\/T-cell lymphoma staged with PET\/CT. Cancer 128, 3943\u20133950. https:\/\/doi.org\/10.1002\/cncr.34473 (2022).","journal-title":"Cancer"},{"key":"5843_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/00000478-199312000-00011","volume":"17","author":"T Sun","year":"1993","unstructured":"Sun, T. et al. Aggressive natural killer cell lymphoma\/leukemia: A recently recognized clinicopathologic entity. Am. J. Surg. Pathol. 17, 1289\u20131299 (1993).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2141.1994.tb04804.x","volume":"86","author":"J Soler","year":"1994","unstructured":"Soler, J. et al. Aggressive natural killer cell leukaemia\/lymphoma in two patients with lethal midline granuloma. Br. J. Haematol. 86, 659\u2013662. https:\/\/doi.org\/10.1111\/j.1365-2141.1994.tb04804.x (1994).","journal-title":"Br. J. Haematol."},{"key":"5843_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2559.2000.00936.x","volume":"37","author":"N Mori","year":"2000","unstructured":"Mori, N. et al. Lymphomatous features of aggressive NK cell leukaemia\/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology 37, 363\u2013371. https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00936.x (2000).","journal-title":"Histopathology"},{"key":"5843_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1046\/j.1365-2559.2000.01029.x","volume":"37","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez, L. & Jaffe, E. S. Commentary: Aggressive NK cell lymphomas: Insights into the spectrum of NK cell derived malignancies. Histopathology 37, 372\u2013374. https:\/\/doi.org\/10.1046\/j.1365-2559.2000.01029.x (2000).","journal-title":"Histopathology"},{"key":"5843_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/gcc.20245","volume":"44","author":"Y Nakashima","year":"2005","unstructured":"Nakashima, Y. et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: Different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 44, 247\u2013255. https:\/\/doi.org\/10.1002\/gcc.20245 (2005).","journal-title":"Genes Chromosomes Cancer"},{"key":"5843_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12185-012-1159-x","volume":"96","author":"N Sekiguchi","year":"2012","unstructured":"Sekiguchi, N. et al. Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms. Int. J. Hematol. 96, 461\u2013468. https:\/\/doi.org\/10.1007\/s12185-012-1159-x (2012).","journal-title":"Int. J. Hematol."},{"key":"5843_CR31","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","volume":"9","author":"O Dufva","year":"2018","unstructured":"Dufva, O. et al. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nat. Commun. 9, 1567. https:\/\/doi.org\/10.1038\/s41467-018-03987-2 (2018).","journal-title":"Nat. Commun."},{"key":"5843_CR32","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/pas.0000000000000634","volume":"40","author":"LM Gao","year":"2016","unstructured":"Gao, L. M. et al. Clinicopathologic characterization of aggressive natural killer cell leukemia involving different tissue sites. Am. J. Surg. Pathol. 40, 836\u2013846. https:\/\/doi.org\/10.1097\/pas.0000000000000634 (2016).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood.V67.4.925.925","volume":"67","author":"LA Fernandez","year":"1986","unstructured":"Fernandez, L. A., Pope, B., Lee, C. & Zayed, E. Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood 67, 925\u2013930. https:\/\/doi.org\/10.1182\/blood.V67.4.925.925 (1986).","journal-title":"Blood"},{"key":"5843_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1182\/blood.V68.5.1065.1065","volume":"68","author":"S Koizumi","year":"1986","unstructured":"Koizumi, S. et al. Malignant clonal expansion of large granular lymphocytes with a Leu- 11+, Leu-7- surface phenotype: In vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood 68, 1065\u20131073. https:\/\/doi.org\/10.1182\/blood.V68.5.1065.1065 (1986).","journal-title":"Blood"},{"key":"5843_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000205617","volume":"80","author":"N Imamura","year":"1988","unstructured":"Imamura, N., Kusunoki, Y., Kajihara, H., Okada, K. & Kuramoto, A. Aggressive natural killer cell leukemia\/lymphoma with N901-positive surface phenotype: evidence for the existence of a third lineage in lymphoid cells. Acta Haematol. 80, 121\u2013128. https:\/\/doi.org\/10.1159\/000205617 (1988).","journal-title":"Acta Haematol."},{"key":"5843_CR36","unstructured":"Jaffe, E. S., Harris, N. L., Stein, H. & J.W., V. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. 3rd edn, Vol 3, International Agency for Research on Cancer (IARC), (2001)."},{"key":"5843_CR37","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn. (International Agency for Research on Cancer (IARC), 2017).","edition":"4"},{"key":"5843_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fped.2018.00292","volume":"6","author":"F Ishida","year":"2018","unstructured":"Ishida, F. Aggressive NK-Cell Leukemia. Front. Pediatr. 6, 292. https:\/\/doi.org\/10.3389\/fped.2018.00292 (2018).","journal-title":"Front. Pediatr."},{"key":"5843_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","volume":"7","author":"YT Tang","year":"2017","unstructured":"Tang, Y. T. et al. Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes. Blood Cancer J. 7, 660. https:\/\/doi.org\/10.1038\/s41408-017-0021-z (2017).","journal-title":"Blood Cancer J."},{"key":"5843_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/cr.2017.146","volume":"28","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia. Cell Res. 28, 172\u2013186. https:\/\/doi.org\/10.1038\/cr.2017.146 (2018).","journal-title":"Cell Res."},{"key":"5843_CR41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/pas.0000000000001518","volume":"44","author":"S El Hussein","year":"2020","unstructured":"El Hussein, S. et al. Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia. Am. J. Surg. Pathol. 44, 1235\u20131243. https:\/\/doi.org\/10.1097\/pas.0000000000001518 (2020).","journal-title":"Am. J. Surg. Pathol."},{"key":"5843_CR42","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3892\/ijo.2012.1669","volume":"41","author":"M Katoh","year":"2012","unstructured":"Katoh, M. Function and cancer genomics of FAT family genes (Review). Int. J. Oncol. 41, 1913\u20131918. https:\/\/doi.org\/10.3892\/ijo.2012.1669 (2012).","journal-title":"Int. J. Oncol."},{"key":"5843_CR43","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.2147\/ott.S111176","volume":"9","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. History and progression of Fat cadherins in health and disease. Onco. Targets Ther. 9, 7337\u20137343. https:\/\/doi.org\/10.2147\/ott.S111176 (2016).","journal-title":"Onco. Targets Ther."},{"key":"5843_CR44","doi-asserted-by":"publisher","first-page":"D1023","DOI":"10.1093\/nar\/gkv1268","volume":"44","author":"M Zhao","year":"2016","unstructured":"Zhao, M., Kim, P., Mitra, R., Zhao, J. & Zhao, Z. TSGene 2.0: An updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res. 44, D1023-1031. https:\/\/doi.org\/10.1093\/nar\/gkv1268 (2016).","journal-title":"Nucleic Acids Res."},{"key":"5843_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13046-022-02461-8","volume":"41","author":"ZG Chen","year":"2022","unstructured":"Chen, Z. G., Saba, N. F. & Teng, Y. The diverse functions of FAT1 in cancer progression: good, bad, or ugly?. J. Exp. Clin. Cancer Res. 41, 248. https:\/\/doi.org\/10.1186\/s13046-022-02461-8 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"5843_CR46","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/leu.2011.319","volume":"26","author":"CE de Bock","year":"2012","unstructured":"de Bock, C. E. et al. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia 26, 918\u2013926. https:\/\/doi.org\/10.1038\/leu.2011.319 (2012).","journal-title":"Leukemia"},{"key":"5843_CR47","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1038\/bcj.2014.44","volume":"4","author":"M Neumann","year":"2014","unstructured":"Neumann, M. et al. FAT1 expression and mutations in adult acute lymphoblastic leukemia. Blood Cancer J. 4, e224. https:\/\/doi.org\/10.1038\/bcj.2014.44 (2014).","journal-title":"Blood Cancer J."},{"key":"5843_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41379-019-0279-8","volume":"33","author":"MA Laginestra","year":"2020","unstructured":"Laginestra, M. A. et al. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Modern Pathol. 33, 179\u2013187. https:\/\/doi.org\/10.1038\/s41379-019-0279-8 (2020).","journal-title":"Modern Pathol."},{"key":"5843_CR49","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","volume":"33","author":"IA Montes-Mojarro","year":"2020","unstructured":"Montes-Mojarro, I. A. et al. Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America. Modern Pathol. 33, 781\u2013791. https:\/\/doi.org\/10.1038\/s41379-019-0415-5 (2020).","journal-title":"Modern Pathol."},{"key":"5843_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133315","author":"C Syrykh","year":"2021","unstructured":"Syrykh, C. et al. Epstein-Barr Virus-Associated T- and NK-Cell lymphoproliferative diseases: A review of clinical and pathological features. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13133315 (2021).","journal-title":"Cancers (Basel)"},{"key":"5843_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong, J. et al. Genomic and transcriptomic characterization of natural killer t cell lymphoma. Cancer Cell 37, 403-419.e406. https:\/\/doi.org\/10.1016\/j.ccell.2020.02.005 (2020).","journal-title":"Cancer Cell"},{"key":"5843_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pathol.2019.09.011","volume":"52","author":"SS-S Hue","year":"2020","unstructured":"Hue, S.S.-S., Oon, M. L., Wang, S., Tan, S.-Y. & Ng, S.-B. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: An update and diagnostic approach. Pathology 52, 111\u2013127. https:\/\/doi.org\/10.1016\/j.pathol.2019.09.011 (2020).","journal-title":"Pathology"},{"key":"5843_CR53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: From bench to clinic. Signal Transduct. Target. Ther. 6, 402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"5843_CR54","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-110416-120628","volume":"35","author":"TA Waldmann","year":"2017","unstructured":"Waldmann, T. A. & Chen, J. Disorders of the JAK\/STAT pathway in t cell lymphoma pathogenesis: Implications for immunotherapy. Ann. Rev. Immunol. 35, 533\u2013550. https:\/\/doi.org\/10.1146\/annurev-immunol-110416-120628 (2017).","journal-title":"Ann. Rev. Immunol."},{"key":"5843_CR55","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1080\/10428190400004513","volume":"45","author":"A Ruskova","year":"2004","unstructured":"Ruskova, A., Thula, R. & Chan, G. Aggressive natural killer-cell leukemia: Report of five cases and review of the literature. Leuk Lymphoma 45, 2427\u20132438. https:\/\/doi.org\/10.1080\/10428190400004513 (2004).","journal-title":"Leuk Lymphoma"},{"key":"5843_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1532\/IJH97.A10612","volume":"85","author":"J Ryder","year":"2007","unstructured":"Ryder, J. et al. Aggressive natural killer cell leukemia: Report of a Chinese series and review of the literature. Int. J. Hematol. 85, 18\u201325. https:\/\/doi.org\/10.1532\/IJH97.A10612 (2007).","journal-title":"Int. J. Hematol."},{"key":"5843_CR57","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/s0002-9440(10)65454-5","volume":"155","author":"LL Siu","year":"1999","unstructured":"Siu, L. L., Wong, K. F., Chan, J. K. & Kwong, Y. L. Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations. Am. J. Pathol. 155, 1419\u20131425. https:\/\/doi.org\/10.1016\/s0002-9440(10)65454-5 (1999).","journal-title":"Am. J. Pathol."},{"key":"5843_CR58","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube, K. et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 118, 3195\u20133204. https:\/\/doi.org\/10.1182\/blood-2011-04-346890 (2011).","journal-title":"Blood"},{"key":"5843_CR59","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","volume":"98","author":"KF Wong","year":"1997","unstructured":"Wong, K. F., Chan, J. K. & Kwong, Y. L. Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia. Br. J. Haematol. 98, 922\u2013926. https:\/\/doi.org\/10.1046\/j.1365-2141.1997.3223139.x (1997).","journal-title":"Br. J. Haematol."},{"key":"5843_CR60","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal, J. et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23, 1139\u20131151. https:\/\/doi.org\/10.1038\/leu.2009.3 (2009).","journal-title":"Leukemia"},{"key":"5843_CR61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"5843_CR62","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing. PLOS Comput. Biol. 12, e1004873. https:\/\/doi.org\/10.1371\/journal.pcbi.1004873 (2016).","journal-title":"PLOS Comput. Biol."},{"key":"5843_CR63","doi-asserted-by":"publisher","first-page":"D564","DOI":"10.1093\/nar\/gkac989","volume":"51","author":"D Marakulina","year":"2022","unstructured":"Marakulina, D. et al. EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes. Nucleic Acids Res. 51, D564\u2013D570. https:\/\/doi.org\/10.1093\/nar\/gkac989 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05843-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:18:56Z","timestamp":1751379536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05843-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5843"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05843-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5740535\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Seoul National University Hospital (No: 2106\u2013128-1228). The need for informed consent was waived due to the retrospective nature of the study by the Institutional Review Board of Seoul National University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"21621"}}